Paul Tudor Jones Says Theres No Chance Warsh Can Secure Fed Rate Cut Market Implications Ashok Leyland Reports Stabilizing Ras Al Khaimah Operations Saudi Manufacturing Plans on Schedule Burberry Shares Surge on Report of Potential Moncler Takeover Bid US Stock Futures and Bond Yields Decline After Reports of Putins Nuclear Doctrine Update H1B Returnees Face Cautious AILed Job Market in India Experts Caution Deutsche Bank Aktiengesellschaft DB Shows Resilient Core Business Despite Market Volatility STAA Q1 2026 Earnings EPS Soars Past Estimates Stock Declines Despite Strong Beat AUTL Q1 2026 Earnings Biotech Posts WiderThanExpected Loss as Stock Edges Higher Orange County Bancorp Inc OBT Q1 2026 Earnings Solid EPS Beat Amid Rising Deposit Costs NEUP Q1 2026 Earnings Narrowing Losses Beat Estimates Sharp Yet Shares Slip RNGR Q1 2026 Earnings EPS Misses Estimates by 3871 Stock Edges Higher Electra Battery Materials Q4 2025 Earnings WiderthanExpected Loss as PreRevenue Company Advances Battery Materials Projects Art Technology Acquisition Corp ARTC Holds Steady Near Support Amid Low Volume Trading GE HealthCare Technologies GEHC Holds Steady Near Resistance Zone Proto Labs PRLB Surges 46 Volume and Sector Tailwinds Drive Breakout Vericel Corporation VCEL Edges Lower as Biotech Sector Faces Headwinds Marcus Corporation MCS Rallies 288 Key Levels in Focus After Positive Move AI Washing Gains Traction as UK Firms Rebrand Automation as Artificial Intelligence KPTI Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Confidence FG Merger II Corp Rights FGMCR Holds Near Key Support After Marginal Decline Spero Therapeutics SPRO Hovers Near Support Amid Modest Decline Key Levels in Focus Childrens Place PLCE Rallies 35 as Oversold Bounce Challenges Resistance Zone FreightCar America RAIL Holds Steady Near Support as Consolidation Persists Revolve Group Inc RVLV Inches Higher as Stock Approaches Key Resistance Zone Sally Beauty Holdings SBH Edges Higher Amid Consolidation Near Support GoDaddy GDDY Slips Over 1 as Stock Tests Key Support Zone Vanda Pharmaceuticals VNDA Shares Rise 375 as Stock Tests Key Resistance